These findings reveal that HOXB‐AS3/EZH2 complex–mediated Dicer suppression plays an important role in sorafenib resistance and cancer stemness and provide potential therapeutic strategies for diagnosing and treating liver cancer patients. The gene discussed is DICER1; the disease is liver cancer.